Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

Innovent Announces the Appointment of Dr. Nageatte Ibrahim as the Oncology Chief Medical Officer (CMO)

SAN FRANCISCO and SUZHOU, China, April 16, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dis...

2024-04-16 08:00 726

TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation

* FDA Fast Track designation granted for TLX101-CDx for glioma (brain cancer) imaging * Collaboration agreement announced for joint development and commercialisation with UCSF * PharmaLogic announced as commercial manufacturing and pharmacy distribution partner MELBOURNE, Australia, April 1...

2024-04-16 06:42 639

【C.S】Cordyceps Sunshine has extended its market footprint in the world's largest traditional Chinese herbal medicine market with the introduction of their Cinnamomum product line.

TAIPEI, April 16, 2024 /PRNewswire/ -- Cordyceps Sunshine Group【C.S】Group, having recently achieved a successful U.S. IPO, hosted the '2024 China International Biomedical Innovation Development Conference and Chinese Rare Medicinal Herbs Cinnamomum Industry Transformation and Upgrade Conference' ...

2024-04-16 06:00 829

【C.S】Cordyceps Sunshine has extended its market footprint in the world's largest traditional Chinese herbal medicine market with the introduction of their Cinnamomum product line.

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

SHANGHAI, April 15, 2024 /PRNewswire/ -- The 89th edition of the China International Medical Equipment Fair (CMEF) witnessed an impressive turnout of over 200,000 attendees from more than 150 countries. Prominent companies in the industry seized the opportunity to sho...

2024-04-15 21:00 847

89th CMEF in Shanghai Elevates Global Medical Device Trade to The Next Level

TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson's Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ -- TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson's Disease is presenting for t...

2024-04-15 15:30 750

GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA

– Gilead Awards US$4 Million Globally (Excluding the United States) Through the Gilead ALL4LIVER Grant – – World Hepatitis Alliance Supports Global Expansion of Gilead ALL4LIVER Grant by Joining Grant Review Committee – – South Korea's Association of Liver Patients and Survivors and the Taiwan re...

2024-04-15 13:06 950

Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA

TOKYO, April 15, 2024 /PRNewswire/ -- Bloomage recently successfully completed the on-site Good Manufacturing Practice (GMP) audit conducted byJapan's Pharmaceuticals and Medical Devices Agency (PMDA). As the official regulatory agency for pharmaceuticals inJapan, the PMDA holds significant resp...

2024-04-15 08:30 856

Bloomage Demonstrates Global Quality Management Excellence through On-Site Audit by Japan's PMDA

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

SHANGHAI, April 13, 2024 /PRNewswire/ -- On Apr. 11, 2024, VITAL HealthCare, one of the 5 core business divisions of the VITAL Group, marked a stunning debut at the 89th China International Medical Equipment Fair (CMEF) inShanghai. Drawing on the Group's core competence in R&D and its wealth of t...

2024-04-13 20:00 2400

Pioneering Cutting-Edge Technologies: High-End Medical Imaging Developer VITAL HealthCare Debuts at CMEF

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

Second major trial for atrial shunt therapy demonstrates importance of patient selection TEWKSBURY, Mass., April 12, 2024 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the recent release of V-Wave's RELIEVE-HF trial data support...

2024-04-12 13:00 1135

Healthcare Revolution 2024: Largest Industry Event Moves to Drive Superior Results in Healthcare and Medical Tourism

PALM BEACH GARDENS, Fla., April 11, 2024 /PRNewswire/ -- The largest annual gathering of key stakeholders in medical travel, healthcare leaders, and self-funded employers is back this year with an exciting new move to help stakeholders achieve superior results, elevate their programs, and redefin...

2024-04-11 23:36 1467

Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease

STOCKHOLM, April 11, 2024 /PRNewswire/ -- IFPA is delighted to announce the 7th IFPA Conference set to take place fromJune 27th to June 29th, 2024, in the picturesque city ofStockholm, Sweden. This year's conference promises to be a pivotal event for experts and stakeholders in the field of psori...

2024-04-11 16:00 1220

Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease

Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan

HELSINKI, Finland, April 11, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform") today announced a strategic partnership whereby CBC Co., Ltd. ("CBC"), will utilize its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoform's cutting-edge nanomedici...

2024-04-11 15:38 1230

CSafe unveils cutting-edge innovations to meet cold chain customer needs

The company will launch three new technologies at the upcoming LogiPharma 2024 event MONROE, Ohio, April 10, 2024 /PRNewswire/ -- CSafe, a leading active and passive temperature-controlled shipping solutions provider for the biopharmaceutical industry, announces it is launching three new technol...

2024-04-10 22:50 1729

3Shape Charts Sustainable Course with Release of Comprehensive Sustainability Report 2023

Highlighted in the company's latest report, 3Shape plans to inspire sustainability awareness in the dental industry through its new 5-year sustainability plan. COPENHAGEN, Denmark, April 10, 2024 /PRNewswire/ -- 3Shape, the global innovator in digital dentistry, is proud to unveil its 2023 Susta...

2024-04-10 18:29 1178

Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare Accreditation with Excellence for Pediatric Medical Travel Services

MIAMI, April 10, 2024 /PRNewswire/ -- Nicklaus Children's Hospital in Miami, Florida, proudly announces its achievement of Global Healthcare Accreditation (GHA) with Excellence for Medical Travel Services. This is Nicklaus Children's Hospital's second GHA Accreditation with Excellence, a distinct...

2024-04-10 18:00 1199

Leading the Way: Nicklaus Children's Hospital Awarded Global Healthcare Accreditation with Excellence for Pediatric Medical Travel Services

ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research

TOKYO, April 10, 2024 /PRNewswire/ -- Starting in 2023, ACROBiosystems has been launching a continuous stream of innovative organoid-related products. Displaying their advancements at key global forums including the 2024 International Organoid Summit, Alzheimer's Research UK Conference 2024, and ...

2024-04-10 14:05 1440

R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm

SHENZHEN, China, April 10, 2024 /PRNewswire/ -- Recently, Kexing Biopharm (688136.SH) announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd., had completed the enrollment of first p...

2024-04-10 11:41 1733

Alphamab Oncology Presented the Dose-escalation Results from JSKN003 in Patients with Advanced/Metastatic Solid Tumors at AACR

* The dose-escalation results of JSKN003 was reported at this AACR conference. * JSKN003 exhibited a favorable tolerability, safety profile and encouraging preliminary antitumor activity in patients with HER2-expressing advanced/metastatic solid tumors. The ORR in patients with HER2+ BC was 100...

2024-04-10 08:40 1512

Neoss Integrate Australia 2024 - Integrate. Educate. Celebrate

QUEENSLAND, Australia, April 9, 2024 /PRNewswire/ -- This summer, Neoss Australia &New Zealand are celebrating 20 years of Intelligent Simplicity and invites the dental community to join us for an exceptional scientific program with over 21 speakers across two days. Taking place on the Gold Coas...

2024-04-09 23:24 1260

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

GAITHERSBURG, Md., April 9, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-04-09 20:00 1143

12 3 4 5 ... 382